Patent Expiry
SNDX: REVUFORJ: recorded patent 12564590 expiry
December 18, 2042 · REVUMENIB CITRATE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 18, 2042
- Company
- Syndax Pharmaceuticals Inc (SNDX)
- Drug
- REVUMENIB CITRATE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
REVUFORJ: recorded patent 12564590 expiry
Orange Book application NDA218944, product 001, listed patent 12564590 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source